Physician profile
Vladimir Redko
NPI 1306844659
$852.28
in general payments reported to CMS, 2019-2025
10 companies · $49.18 in 2025
The $49.18 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $70.64 · 2021: $40.09 · 2022: $185 · 2023: $71.40 · 2024: $124 · 2025: $49.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $274.32 | 2019-2020 | |
| Tersera Therapeutics LLC | $209.93 | 2020-2024 | Prialt |
| Boston Scientific Corporation | $141.41 | 2019-2025 | General - Pain Management |
| Abbvie INC. | $80.58 | 2022 | |
| Pfizer INC. | $40.91 | 2019-2020 | |
| Saluda Medical Americas, INC. | $31.30 | 2025 | Evoke |
| Supernus Pharmaceuticals, INC. | $21.50 | 2020 | |
| Medtronic, INC. | $21.28 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.81 | 2023 | Iovera |
| Mdd US Operations, LLC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vladimir Redko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.